Madrigal Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $103,320 | $62,175 | $14,638 | $0 |
Gross Profit | 100,310 | 60,023 | 13,735 | -168 |
EBITDA | -55,555 | -102,987 | -148,048 | -143,535 |
EBIT | -55,918 | -103,285 | -148,315 | -143,703 |
Net Income | -59,416 | -106,964 | -151,971 | -147,541 |
Net Change In Cash | 103,320 | 62,175 | 14,638 | 0 |
Free Cash Flow | -104,681 | -67,763 | -140,076 | -149,514 |
Cash | 100,019 | 232,684 | 499,597 | 622,517 |
Basic Shares | 21,272 | 21,745 | 21,402 | 20,001 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $180,133 | $0 | $0 | $37 |
Gross Profit | 173,900 | -527 | -467 | 273 |
EBITDA | -450,125 | -379,969 | -293,104 | -242,077 |
EBIT | -451,221 | -380,496 | -293,571 | -242,482 |
Net Income | -465,892 | -373,630 | -299,314 | -241,078 |
Net Change In Cash | 180,133 | 0 | 0 | 37 |
Cost of Revenue | 295,280 | -17,735 | ||
Free Cash Flow | -457,034 | -325,709 | -225,074 | -184,126 |
Cash | 100,019 | 99,915 | 331,549 | 36,269 |
Basic Shares | 21,272 | 18,687 | 17,137 | 16,535 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$2.71 |
2024-09-30 | -$4.92 |
2024-06-30 | -$7.10 |
2024-03-31 | -$7.38 |
